Nephrotic syndrome due to membranous nephropathy associated with metastatic prostate cancer: Rapid remission after initial endocrine therapy

Citation
H. Matsuura et al., Nephrotic syndrome due to membranous nephropathy associated with metastatic prostate cancer: Rapid remission after initial endocrine therapy, NEPHRON, 84(1), 2000, pp. 75-78
Citations number
18
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
NEPHRON
ISSN journal
00282766 → ACNP
Volume
84
Issue
1
Year of publication
2000
Pages
75 - 78
Database
ISI
SICI code
0028-2766(200001)84:1<75:NSDTMN>2.0.ZU;2-I
Abstract
A case of severe nephrotic syndrome (urinary protein excretion 12.9 g/day) due to membranous nephropathy associated with untreated prostate cancer and multiple bone metastases is described. A combination of initial endocrine treatment and steroid therapy resulted in normalization of prostate-specifi c antigen levels followed by a rapid decrease of urinary protein excretion within 4 months, No proteinuria was subsequently detected. Seven months aft er the initiation of therapy, the patient remained well with complete clini cal remission from the nephrotic syndrome; This rapid achievement of remiss ion may have been due to tumor shrinkage by androgen ablation in addition t o steroid therapy of the membranous nephropathy. The nephrotic syndrome is a rare complication of pi-estate cancer, and, to the best of our knowledge, no previous cases have been reported of membranous nephropathy as one of t he first disease manifestations. Copyright (C) 2000 S. Karger AG, Basel.